Use of antisense oligodeoxynucleotide to determine δ-opioid receptor involvement in [d-Ala2]deltorphin II-induced locomotor hyperactivity
- 1 June 1996
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 59 (4) , PL69-PL73
- https://doi.org/10.1016/0024-3205(96)00307-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacologyTrends in Pharmacological Sciences, 1995
- The Use of Antisense Oligodeoxynucleotides to Block the Spinal Effects of κ1 Agonist-Induced Antinociception in the MouseAnalgesia, 1995
- Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptorLife Sciences, 1994
- Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in ratsBrain Research, 1994
- Antisense oligodeoxynucleotide to a δ-opioid receptor selectivily blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouseEuropean Journal of Pharmacology, 1994
- Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptorNeuron, 1994
- Antisense oligonucleotide strategies in neuropharmacologyTrends in Pharmacological Sciences, 1994
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Cloning of a Delta Opioid Receptor by Functional ExpressionScience, 1992
- Behavioural effects of deltorphins in ratsEuropean Journal of Pharmacology, 1991